Novo Nordisk plans to eliminate approximately 250 jobs in the U.S., according to a spokesman from the company, as well as add an undetermined number of staff to newly created positions.   Novo Nordisk employs more than 42,000 people in 79 countries. The company, a specialist in diabetes, has seen more modest growth in recent years as a result of pricing pressures in the U.S., which accounts for approximately half of its revenue. Annual revenues were flat at $17.9 billion in 2017, and earnings ...